We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Fewer Warning Letters on Marketing Likely in Wake of Caronia Verdict
Fewer Warning Letters on Marketing Likely in Wake of Caronia Verdict
January 25, 2013
A short-term drop-off in FDA warning and untitled letters flagging off-label marketing is likely in the wake of the 2nd Circuit’s decision in U.S. v. Caronia.